[Cancer of the ovary. New therapeutic approaches]

Presse Med. 1994 Jan 22;23(2):67-8.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cisplatin / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Docetaxel
  • Doxorubicin / therapeutic use
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Interferon-gamma / therapeutic use
  • Ovarian Neoplasms / therapy*
  • Paclitaxel / analogs & derivatives
  • Paclitaxel / therapeutic use*
  • Taxoids*

Substances

  • Antineoplastic Agents, Phytogenic
  • Taxoids
  • Granulocyte Colony-Stimulating Factor
  • Docetaxel
  • Doxorubicin
  • Interferon-gamma
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Cyclophosphamide
  • Paclitaxel
  • Cisplatin

Supplementary concepts

  • CISCA protocol